![](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/S2603924920300835:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w96p5LBcBpyJTqfwgorxm+Ow=)
Área salud
Most women with breast cancer about to initiate aromatase inhibitors already have bone loss
Women with breast cancer who receive aromatase inhibitors (AI) are at risk of bone mass loss and bone fracture. Many of these women have been previously treated with chemotherapy and/or tamoxifen, also with known deleterious […]